Trial ID
TOS-358-001
Sponsor ID
Totus
A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Locations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
NP-G2-044-P2-01
Sponsor ID
Novita
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
KB-0742-1001
Sponsor ID
Kronos Bio
“Phase 1, first-in-human, open-label dose escalation and cohort expansion study of KB-0742 in patients with relapsed or refractory solid tumors or non-Hodgkin lymphoma”
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
